Latest AI and machine learning research in hemophilia for healthcare professionals.
Accurate and robust prediction of drug-target affinity (DTA) plays a critical role in drug discovery. While deep learning has advanced DTA prediction, existing methods struggle with limited training data and poor generalization. In this study, we propose AdaMBind, a novel DTA prediction model based on meta-learning framework with an adaptive task module designed for low-data scenarios. It employs ...
Targeted covalent inhibitors (TCIs) have emerged as a promising antiviral modality, functioning through irreversible or reversible modification of conserved nucleophilic residues within essential viral proteins. These agents are increasingly recognized in antiviral drug discovery due to their potential to achieve enhanced target engagement and prolonged pharmacological effects when appropriately d...
BACKGROUND: Ferroptosis plays a critical role in immune regulation and tumor microenvironment remodeling. However, its therapeutic potential in enhanc...
Pancreatic cancer is characterized by early metastasis and high aggressiveness, highlighting the need for novel molecular biomarkers to improve progno...
Breast and ovarian cancers are still one of the most prevalent causes of cancer death among the women in all parts of the world, mostly occurring at a...
Alzheimer's Disease (AD) is a degenerative disorder of the brain that causes a gradual loss of cognitive function. The cholinergic hypothesis suggests...
Patients with advanced lung adenocarcinoma have a range of treatment options, including targeted therapy and gene assay-guided chemotherapy. The aim o...
BACKGROUND: Musculoskeletal ultrasound (US) is a noninvasive tool for joint assessment in persons with hemophilia. Early detection of joint bleeding u...
Recent advances in structural biology, functional genomics, and artificial intelligence (AI) have expanded understanding of the solute carrier (SLC) t...
Tau-protein aggregation is a central pathological feature of Alzheimer's disease, so blocking fibril growth is an attractive therapeutic goal. We cura...
Neoadjuvant systemic therapy has emerged as a strategy to improve outcomes in high-risk localized genitourinary malignancies. In bladder cancer, neoad...
Colchicine, a well-known microtubule assembly inhibitor that binds to β-tubulin, has limited clinical utility due to high systemic toxicity. To enhanc...
BACKGROUND: Immune checkpoint inhibitor therapy (ICI) with nivolumab+ipilimumab is a first-line (1L) standard for metastatic clear cell renal cell car...
Vascular endothelial growth factor receptor 2 (VEGFR2) is a central regulator of angiogenesis and endothelial signaling and represents a validated the...
We developed a novel, explainable artificial intelligence (AI)-driven prognostic model using a contemporary single-centre cohort of 668 patients under...
UNLABELLED: Multiplexed imaging of tissues is an approach that holds promise for improving early detection, diagnosis, and treatment of cancer. In thi...
OBJECTIVE: This study aimed to characterize adverse drug reactions (ADRs) associated with programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) in...
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a major cause of severe thrombocytopenia, intracranial hemorrhage, and long-term neurologica...
Nanoparticle-based drug delivery faces persistent challenges, including complex fabrication processes and limited lesional accumulation. Here we intro...
Hemophilia A is a rare inherited bleeding disorder typically managed with coagulation factor VIII (FVIII) replacement therapy. Designing personalized ...